Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
Add more filters










Publication year range
1.
Int J Cancer ; 72(1): 133-41, 1997 Jul 03.
Article in English | MEDLINE | ID: mdl-9212234

ABSTRACT

Cytofluorimetric and reverse-transcription polymerase chain reaction (RT-PCR) analysis showed that adriamycin-resistant (ADRR), but not sensitive (WT), MCF-7 human mammary carcinoma cell lines express alpha4beta1 and alpha5beta1 integrins. ADR(R) cells adhere to fibronectin (FN), and only alpha5beta1 is involved in cell adhesion to this glycoprotein, while alpha4beta1 mediates cell binding to the cellular counter-receptor VCAM-1. Proliferation assays showed that FN, but not VCAM-1, delivers a mitogenic signal to quiescent ADR(R) MCF-7 cells. The activating signal is mediated by alpha5beta1, since cell proliferation is inhibited in the presence of RGD peptide or specific antibody. Cell cycle analysis demonstrated that cell/FN interaction induces the re-entry of ADR(R) MCF-7 into S phase, and prevents them from undergoing serum deprivation-induced apoptosis. Our data suggest that the presence of alpha5beta1 on the resistant cells enables them to draw advantage from FN for both cell growth and survival.


Subject(s)
Breast Neoplasms/metabolism , Doxorubicin/pharmacology , Integrin beta1/metabolism , Receptors, Fibronectin/metabolism , Breast Neoplasms/drug therapy , Cell Adhesion , Cell Division , Drug Resistance, Neoplasm , Humans , Integrin beta1/physiology , Polymerase Chain Reaction , Receptors, Fibronectin/physiology , Tumor Cells, Cultured , Vascular Cell Adhesion Molecule-1/pharmacology
2.
Biochem J ; 321 ( Pt 2): 497-501, 1997 Jan 15.
Article in English | MEDLINE | ID: mdl-9020886

ABSTRACT

Interleukin 1-beta (IL1-beta) is a pleiotropic cytokine that stimulates a number of signal transduction pathways in cells, leading to different cellular responses. In this study we investigated the signal transduction pathways activated by IL1-beta in two different human cell lines: RD/TE671, a rhabdomyosarcoma, and EJ, a bladder-derived carcinoma. We showed that this cytokine induced the activation of protein kinase C-zeta (PKC-zeta) and the accumulation of a putative physiological PKC-zeta activator, phosphatidic acid [Limatola, Schaap, Moolenaar and van Blitterswijk (1994) Biochem. J. 304, 1001-1008]. Exogenously supplied phospholipase D, which generated cellular phosphatidic acid, was able to mimic the cytokine effect, supporting the hypothesis that this lipid second messenger might contribute to cytokine-induced PKC-zeta activation. In addition, we show that IL1-beta stimulation of BOSC23 cells, transiently overexpressing PKC-zeta, induced an increase in PKC-zeta autophosphorylation. These results give the first direct evidence that IL1-beta can activate this atypical PKC isoform and suggest that this enzyme might be involved in mediating some of the biological effects induced by IL1-beta.


Subject(s)
Interleukin-1/pharmacology , Isoenzymes/metabolism , Phospholipase D/metabolism , Protein Kinase C/metabolism , Cell Line , Enzyme Activation/drug effects , Humans , Isoenzymes/drug effects , Kidney , Phosphatidic Acids/metabolism , Protein Kinase C/drug effects , Rhabdomyosarcoma , Sphingomyelin Phosphodiesterase/metabolism , Tumor Cells, Cultured
3.
J Immunol ; 157(7): 2759-63, 1996 Oct 01.
Article in English | MEDLINE | ID: mdl-8816377

ABSTRACT

Several chemokine receptors have been cloned and shown to belong to a superfamily of seven transmembrane, G protein-coupled receptors. We report here the molecular cloning of TER1, a novel human chemokine receptor-like gene. The amino acid sequence deduced from the TER1 cDNA shows 43, 40, 40, and 39% identity to CCR4, CCR5, CCR1, and CCR2B beta chemokine receptors, respectively. By the use of fluorescent in situ hybridization, we have mapped the TER1 gene to chromosome 3p21, clustered with other chemokine receptor genes. By Northern blot analysis, TER1 mRNA is found to be expressed in the thymus, spleen, and at barely detectable levels in peripheral blood lymphocytes. Moreover, TER1 message in abundant in the NK cell line NK3.3 and in the T cell line MOLT-4. The restricted TER1 expression in cells and tissues of the lymphoid lineage suggests that this receptor may play a role in regulating immune functions.


Subject(s)
Genes , Lymphoid Tissue/metabolism , Receptors, Chemokine , Receptors, Cytokine/genetics , Amino Acid Sequence , Chromosome Mapping , Chromosomes, Human, Pair 3 , Cloning, Molecular , Gene Expression , Humans , Molecular Sequence Data , RNA, Messenger/biosynthesis , Receptors, CCR8 , Receptors, Cytokine/metabolism , Sequence Alignment , Sequence Homology, Amino Acid
4.
Anticancer Res ; 16(2): 581-8, 1996.
Article in English | MEDLINE | ID: mdl-8687101

ABSTRACT

Cytofluorimetric and biochemical analysis in two different grade human bladder cancer cell lines showed that G3 EJ cells exhibited higher levels of alpha5beta1 and alpha6beta1 heterodimers, and the G2 RT112 cell line higher levels of alpha2beta1. Alpha6/beta4 receptor was detected only in RT112 cells. Adhesion assays with extracellular matrix proteins indicated that both cells bound to fibronectin, laminin and collagen 1, the adhesive properties being related to the integrin profile. Inhibition tests revealed that alpha5beta1 mediated adhesion to fibronectin, alpha3beta1 and alpha6beta1 to laminin, and that alpha2beta1 was the main mediator of adhesion to collagen I in both cell lines. In EJ but not in RT112 cells, tumor necrosis factor-alpha induced the upregulation of alpha2, which mediated increased adhesion to collagen I. The different effects of TNFalpha on the two cell lines were not attributable to differences in tumor necrosis factor responsiveness, as both cells expressed comparable levels of tumor necrosis factor receptor-1 and the tumor necrosis factor-inducible intercellular adhesion molecule-1.


Subject(s)
Carcinoma, Transitional Cell/metabolism , Integrin beta1/metabolism , Neoplasm Proteins/metabolism , Receptors, Antigen/physiology , Urinary Bladder Neoplasms/metabolism , Cell Adhesion/drug effects , Collagen/metabolism , Fibronectins/metabolism , Humans , Laminin/metabolism , Tumor Cells, Cultured , Tumor Necrosis Factor-alpha/pharmacology
5.
Med Ref Serv Q ; 10(4): 15-27, 1991.
Article in English | MEDLINE | ID: mdl-10117782

ABSTRACT

CD-ROM database products are in widespread use and offer potential cost savings over online products. Many libraries would find a cost-benefit analysis useful. Libraries often do not have sufficient funding simply to underwrite all costs related to CD-ROM workstations. Inexpensive menuing software permits usage tracking for data analysis and cost recovery of CD-ROM subscription, start-up, and operating costs. This article will explore the approach taken at the Fox Chase Cancer Center in Philadelphia to recover CD-ROM related expenses through user fees.


Subject(s)
CD-ROM/economics , Cost-Benefit Analysis/methods , Libraries, Hospital/economics , CD-ROM/statistics & numerical data , Cancer Care Facilities/economics , Data Collection/methods , Fees and Charges , Philadelphia , Software , User-Computer Interface
6.
Biochim Biophys Acta ; 1034(3): 333-6, 1990 Jun 20.
Article in English | MEDLINE | ID: mdl-2114174

ABSTRACT

In this study, several methods for controlled labelling of synthetic peptides by the use of fluorescent compounds (fluorescein isothiocyanate and dimethylaminonaphthalene sulfonyl chloride) were investigated. The first reagent yielded monofluoresceinated, active compounds only when the peptides lacked lysine residues. Monolabelling of peptides in solution with dimethylaminonaphthalenesulphonyl chloride was hindered by the broad reactivity of the reagent, but was achieved by reacting the fluorochrome on protected resin-bound peptides in solid-phase synthesis. The remarkable stability of the linkage allowed the cleavage of the peptide from the resin and deprotection of side-chain functions without hydrolysis of the labelled group. The binding of antipeptide antibodies to the labelled fragments was then estimated using different techniques.


Subject(s)
Fluorescent Dyes , Peptides , Amino Acid Sequence , Dansyl Compounds , Enzyme-Linked Immunosorbent Assay , Fluorescein-5-isothiocyanate , Fluoresceins , Microscopy, Fluorescence , Molecular Sequence Data , Spectrometry, Fluorescence , Thiocyanates
7.
Anticancer Res ; 10(3): 565-77, 1990.
Article in English | MEDLINE | ID: mdl-2369079

ABSTRACT

The treatment of exponentially-growing B16 melanoma cells with teniposide causes a dose- and time-dependent decrease of cell survival. By means of the nucleoid technique, the formation of double strand breaks was demonstrated in the nuclei of the treated cells, indicating a possible involvement of topoisomerase II. DNA double strand breaks were rapidly but ineffectively repaired. Morphometric and densitometric analyses showed that teniposide treatment causes a considerable increase of nuclear area, nuclear DNA and cell size, associated with a lowering of the mitotic index to less than one hundredth of that of the controls. The cytocidal effect of VM-26 can be potentiated by the addition of a non-lethal dose of lonidamine, whose synergism is particularly evident at low teniposide concentrations.


Subject(s)
Antineoplastic Agents/pharmacology , Indazoles/pharmacology , Podophyllotoxin/analogs & derivatives , Pyrazoles/pharmacology , Teniposide/pharmacology , Tumor Cells, Cultured/drug effects , Animals , Cell Division/drug effects , Cell Line , Cell Nucleus/drug effects , Cell Nucleus/ultrastructure , Cell Survival/drug effects , Clone Cells , Drug Interactions , Drug Screening Assays, Antitumor , Melanoma, Experimental , Mice , Mitotic Index/drug effects , Tumor Cells, Cultured/cytology
8.
Med Ref Serv Q ; 9(2): 21-39, 1990.
Article in English | MEDLINE | ID: mdl-10113021

ABSTRACT

The NEXIS online system is used a great deal in business and law libraries, but has been virtually overlooked by medical librarians due to their perception of the system as expensive and difficult to search. The changing health care environment has placed new demands on medical searchers for just the type of legal, business, governmental, and news information found in the full-text files in NEXIS. Through the recent introduction of News Plus software, NEXIS can be searched as never before by those unaccustomed to full-text search techniques. Besides simplifying the search process, the new software has cost-saving features since search building and file selection are accomplished offline, and several activities may be done simultaneously. NEXIS via News Plus should be seriously considered as an addition to the repertoire of online systems accessed by medical librarians.


Subject(s)
Cancer Care Facilities , Databases, Bibliographic , Libraries, Hospital , Hospital Bed Capacity, 100 to 299 , Online Systems , Philadelphia , Software Design , User-Computer Interface
9.
Int Arch Allergy Appl Immunol ; 90(3): 207-12, 1989.
Article in English | MEDLINE | ID: mdl-2592111

ABSTRACT

A quantitative assay for determining the polymorphonuclear neutrophil (PMN) stimulation is described. The method is based on the inactivation of lambda vector phages that occurs after a brief exposure to stimulated PMNs. The determination of the number of residual plaque-forming units on the appropriate bacterial host allows a reproducible and sensitive quantitative assay for measuring the stimulation level of the PMN. In comparison with other methods that employ bacteria or eukaryotic cells, this assay provides several advantages and can be used for investigating the biochemical and physiological processes responsible for PMN stimulation.


Subject(s)
Coliphages/growth & development , Neutrophils/physiology , Azides/pharmacology , Humans , In Vitro Techniques , Neutrophils/drug effects , Potassium Cyanide/pharmacology , Sodium Azide , Taurine/pharmacology , Tetradecanoylphorbol Acetate/pharmacology , Time Factors , Viral Plaque Assay
10.
Exp Mol Pathol ; 49(3): 361-72, 1988 Dec.
Article in English | MEDLINE | ID: mdl-3197815

ABSTRACT

The incubation of human erythrocytes with increasing levels of the antineoplastic drug Lonidamine clearly indicated a dose-dependent effect on the lipid composition of the plasma membranes. A selective transfer of phosphatidylcholine and cholesterol from membrane to incubation medium and the consequent enrichment in phosphatidylethanolamine of the membrane itself was observed. Moreover, the membranes were found to contain increasing levels of the drug which was incorporated at a constant membrane/medium partition ratio. The changes in composition appeared to be consistent with morphological alterations observed by scanning and freeze-fracture electron microscopy demonstrating changes in cell shape, the presence of numerous intracellular vesicles, and a membrane protein rearrangement. The analysis of intact red cells by nuclear magnetic resonance ruled out the possibility that the alterations described above could be due to an ATP depletion. This further confirmed that cell membranes were the primary target of the Lonidamine action, the previously described energy metabolism impairment being a consequence of a selective damage of cellular membranes, probably originating from the incorporation of the drug into the lipid bilayer.


Subject(s)
Erythrocyte Membrane/drug effects , Indazoles/pharmacology , Membrane Lipids/metabolism , Pyrazoles/pharmacology , Cholesterol , Chromatography, High Pressure Liquid , Dose-Response Relationship, Drug , Freeze Fracturing , Humans , In Vitro Techniques , Membrane Proteins/physiology , Microscopy, Electron, Scanning , Phosphatidylcholines , Solubility
11.
Exp Mol Pathol ; 46(3): 279-93, 1987 Jun.
Article in English | MEDLINE | ID: mdl-2954847

ABSTRACT

The effect of hyperthermia (1 hr, 41 degrees C) on the functional properties of Ehrlich ascites tumor mitochondria was investigated. Mitochondria isolated from Ehrlich ascites tumor after exposure of whole cells to 41 degrees C for 1 hr still phosphorylate and maintain a normal acceptor control ratio (ACR). The temperature decreases state 4 and ADP-and FCCP-stimulated respiration on various substrates entering at three energy-conserving sites of the respiratory chain. The inhibition of oxygen consumption by NAD- and FAD-linked substrates was 40% for state 4 and 70% for ADP- or FCCP-stimulated respiration. State 4 and FCCP-stimulated respiration of mitochondria on TMPD + ascorbate was affected 38% and 45%, respectively. ATPase activity was unaffected by hyperthermia, indicating that under these experimental conditions, the inhibition of ADP-stimulated respiration does not depend on an effect on either Fo F1-ATPase or adenine translocase, the activity of which is required for ATP entry prior to ATPase activity. Because of the inability to detect a specific site of action of temperature, it is conceivable that hyperthermia might inhibit substrate oxidation by altering some components of the inner mitochondrial membrane, which regulates the kinetic properties of the membrane-associated enzymes.


Subject(s)
Carcinoma, Ehrlich Tumor/metabolism , Hot Temperature , Mitochondria/metabolism , Adenosine Triphosphatases/metabolism , Animals , Carcinoma, Ehrlich Tumor/ultrastructure , Cells, Cultured , Electron Transport , Male , Mice , Mitochondria/enzymology , Oxidation-Reduction , Oxygen Consumption
12.
Exp Mol Pathol ; 46(1): 15-30, 1987 Feb.
Article in English | MEDLINE | ID: mdl-3492392

ABSTRACT

Lonidamine, a derivative of indazol carboxylic acid, has been found to exert a powerful inhibitory effect on oxygen consumption and aerobic glycolysis of neoplastic cells through mechanisms yet to be defined. Recent freeze-fracture studies have shown that Lonidamine alters the distribution of intramembranous particles in the plasma membrane, suggesting that the cell membranes, rather than the energy metabolism, are the drug's primary target. The present study was carried out to further evaluate the effects of Lonidamine on cell membranes, using normal human erythrocytes and T lymphocytes and Ehrlich ascites tumor cells as cell models. These studies indicate that plasma and mitochondrial membranes are the primary site of the drug's action, though other cell membranes seem to be affected as well. Thus, Lonidamine inhibition of energy metabolism in nucleated cells reported in previous studies must be considered as a consequence of the structural damage of the inner and outer mitochondrial membranes, which in turn affects respiration and glycolysis and then cell viability.


Subject(s)
Carcinoma, Ehrlich Tumor/ultrastructure , Cell Membrane/drug effects , Erythrocyte Membrane/drug effects , Indazoles/pharmacology , Intracellular Membranes/drug effects , Mitochondria/drug effects , Pyrazoles/pharmacology , T-Lymphocytes/drug effects , Animals , Cell Membrane/ultrastructure , Erythrocyte Membrane/ultrastructure , Glycolysis/drug effects , Hexokinase/metabolism , Humans , Intracellular Membranes/ultrastructure , Membrane Proteins/metabolism , Mice , Microscopy, Electron , Mitochondria/metabolism , Mitochondria/ultrastructure , Oxygen Consumption/drug effects , T-Lymphocytes/ultrastructure
13.
Exp Mol Pathol ; 44(2): 197-206, 1986 Apr.
Article in English | MEDLINE | ID: mdl-3699138

ABSTRACT

The ability of lonidamine [1-(2,4)-dichlorobenzyl-1H-indazol-3-carboxylic acid], to induce a stress response in human and murine cultured melanoma cells has been demonstrated. In the M14 and M10 human melanoma cell lines, lonidamine enhances the synthesis of a unique set of proteins, characterized by SDS-PAGE by an Mr of about 72 kDa. In the B16 murine melanoma cell line, exposure to lonidamine increases the synthetic rate of two polypeptides of mol mass 86 and 72 kDa, respectively. Lonidamine is a drug which specifically acts on mitochondria. Therefore the observation that it can also promote a stress response indicates that the mitochondria might be one of the primary cellular targets and postulates a causal relationship between an impairment of the energy supply and induction of stress protein synthesis.


Subject(s)
Heat-Shock Proteins/biosynthesis , Indazoles/pharmacology , Melanoma/metabolism , Pyrazoles/pharmacology , Animals , Cell Line , Electrophoresis, Polyacrylamide Gel , Energy Metabolism/drug effects , Humans , Mice , Mitochondria/drug effects , Neoplasm Proteins/biosynthesis
14.
Exp Mol Pathol ; 42(3): 293-305, 1985 Jun.
Article in English | MEDLINE | ID: mdl-3996552

ABSTRACT

The action of lonidamine, 1,(2,4 dichlorobenzyl)-1H-indazol-3-carboxylic acid, on protein synthesis of neoplastic cells growing both in vivo and in vitro has been investigated. Lonidamine decreases amino acid incorporation in all cells tested, although the inhibition is partially relieved by glucose. The inhibition of labeled precursors into acid-insoluble material cannot be ascribed to an impairment of amino acid uptake which, on the contrary, is enhanced by the drug. Tests on cell-free systems showed that lonidamine does not inhibit the tobacco mosaic virus (TMV)-mRNA-directed in vitro protein synthesis, thus indicating that protein synthetic machinery per se is not affected. The inhibition of the rate of protein synthesis achieved by lonidamine must be ascribed to an effect on energy-yielding processes with a mechanism similar to that observed in other metabolic inhibitors. Lonidamine, however, because of its capacity to inhibit both respiration and glycolysis in neoplastic cells, is effective at 10 to 20 times lower concentrations. DNP and oligomycin potentiate the inhibitory effect of lonidamine on the rate of protein synthesis. This finding substantiates the idea that neoplastic cells, including those growing in ascitic form, utilize mitochondrial oxidative phosphorylation as the main source of ATP for their biosynthetic processes.


Subject(s)
Antineoplastic Agents/pharmacology , Indazoles/pharmacology , Neoplasm Proteins/biosynthesis , Pyrazoles/pharmacology , Amino Acids/metabolism , Animals , Carcinoma, Ehrlich Tumor/metabolism , Cell Line , Cell-Free System , Dinitrobenzenes/pharmacology , Glycolysis/drug effects , Humans , Kinetics , Lactates/biosynthesis , Leukemia, Experimental/metabolism , Male , Melanoma/metabolism , Mice , Oligomycins/pharmacology , Rabbits , Sarcoma, Experimental/metabolism
15.
Exp Mol Pathol ; 42(2): 194-205, 1985 Apr.
Article in English | MEDLINE | ID: mdl-3156759

ABSTRACT

The effect of lonidamine on the aerobic glycolysis and on the ultrastructure of normal and phytohemagglutinin-stimulated human peripheral blood lymphocytes has been investigated. In quiescent lymphocytes lonidamine does not affect aerobic lactate production and does not induce ultrastructural modifications. On the contrary, lymphocytes stimulated with phytohemagglutinin become susceptible to lonidamine inhibition. The rate of lactate production is decreased by 50% and mitochondria appear swollen with rarified matrix and disrupted cristae. The different effect of lonidamine can be ascribed both to the biochemical modifications induced by phytohemagglutinin and to the mechanism of lonidamine itself. Phytohemagglutinin increases the activity of hexokinase and phosphofructokinase and determines a shift of cytoplasmatic hexokinase toward the mitochondria-bound form which is responsible for the increased lactate production. This interpretation is supported by the finding that lonidamine, which specifically inhibits mitochondria-bound hexokinase only when mitochondria are in a condensed state, decreases lactate production to a value similar to that found in unstimulated cells. The inability of lonidamine to affect the aerobic glycolysis of quiescent lymphocytes can be interpreted along the same line. On this basis it is suggested that the inhibition of mitochondria-bound hexokinase might be ascribed to marked changes in membrane conformation that affect the activity of membrane-associated enzymes, rather than to a direct effect of the enzyme itself.


Subject(s)
Glycolysis/drug effects , Indazoles/pharmacology , Lymphocytes/drug effects , Pyrazoles/pharmacology , Cell Survival/drug effects , Hexokinase/metabolism , Humans , Lactates/metabolism , Lactic Acid , Lymphocyte Activation/drug effects , Lymphocytes/metabolism , Lymphocytes/ultrastructure , Mitochondrial Swelling/drug effects , Ouabain/pharmacology , Phosphofructokinase-1/metabolism , Phytohemagglutinins/pharmacology
16.
Oncology ; 41 Suppl 1: 15-29, 1984.
Article in English | MEDLINE | ID: mdl-6717891

ABSTRACT

Lonidamine induces in murine and human tumor cells severe morphological damage of the mitochondria and other cytoplasmic structures both 'in vitro' and 'in vivo'. Biochemical studies have demonstrated that the drug decreases oxygen consumption and lactate production. The sensitivity of human tumor cells is not related to their histotype. Lonidamine's effects on mitochondria, glycolysis, pentose phosphate pathway, and aromatase activity are discussed.


Subject(s)
Carcinoma, Ehrlich Tumor/ultrastructure , Indazoles/pharmacology , Neoplasms/ultrastructure , Pyrazoles/pharmacology , Animals , Dose-Response Relationship, Drug , Humans , In Vitro Techniques , Lactates/metabolism , Lactic Acid , Leukemia, Experimental/pathology , Male , Mice , Mice, Inbred Strains , Microscopy, Electron , Microscopy, Electron, Scanning , Mitochondria/drug effects , Rats , Rats, Inbred Strains , Time Factors
17.
Oncology ; 41 Suppl 1: 7-14, 1984.
Article in English | MEDLINE | ID: mdl-6609324

ABSTRACT

The in vitro inhibitory activity of Lonidamine on the aerobic glycolysis of normal as well as leukemic lymphocytes has been investigated. The extent of the impairment of lactate production induced by Lonidamine on normal thymus (T)- and bone marrow (B)-derived lymphocytes was found to be dependent on their source of origin, i.e. residing or circulating pool. Among leukemia tested 'null' and B cell leukemias appeared the most affected metabolically by the compound. Administration in vivo of the drug to the patient with B cell chronic leukemia resulted in a decrease of lactate production by leukemic cells comparable to that induced in vitro. These metabolic changes were paralleled in normal, as well as in leukemic cells by ultrastructural lesions, mainly confined to the mitochondrial compartment.


Subject(s)
B-Lymphocytes/metabolism , Glycolysis/drug effects , Indazoles/pharmacology , Leukemia/blood , Pyrazoles/pharmacology , T-Lymphocytes/metabolism , Aerobiosis , B-Lymphocytes/ultrastructure , Dose-Response Relationship, Drug , Humans , In Vitro Techniques , Lactates/blood , Lactic Acid , Microscopy, Electron , Phenotype , T-Lymphocytes/ultrastructure
18.
Exp Mol Pathol ; 38(3): 322-35, 1983 Jun.
Article in English | MEDLINE | ID: mdl-6852206

ABSTRACT

The effect of the association of Gossypol and Lonidamine on the energy metabolism of Ehrlich ascites tumor cells has been investigated. The action of the drug on tumor cells was studied by addition of the drugs to cells harvested from Swiss male mice. The results may be summarized as follows: (1) Low concentrations of Gossypol increase the rate of oxygen consumption by uncoupling oxidative phosphorylation. High concentrations result in an inhibition of oxygen consumption with a mechanism that must be regarded as not directly related to the uncoupling activity. (2) Gossypol, at concentrations at which it exerts an uncoupling activity, stimulates mitochondrial ATPase which in turn increases the aerobic and anaerobic rates of lactate production. The decrease of glycolysis at high concentrations of Gossypol does not depend on the inhibition of enzymes of the glycolytic pathway, but must be ascribed to cell death. (3) The association of a low concentration of Gossypol with Lonidamine brings about a further inhibition of oxygen consumption. Moreover, Lonidamine abolishes the stimulation of glycolysis induced by Gossypol and lowers lactate production to values that are quite similar to those found with Lonidamine alone. (4) It may be concluded that the association of Gossypol and Lonidamine results in a very effective decrease of the energy requirements of cancer cells.


Subject(s)
Carcinoma, Ehrlich Tumor/metabolism , Energy Metabolism/drug effects , Gossypol/pharmacology , Indazoles/pharmacology , Pyrazoles/pharmacology , Aerobiosis , Anaerobiosis , Animals , Carcinoma, Ehrlich Tumor/pathology , Carcinoma, Ehrlich Tumor/ultrastructure , Dinitrophenols/pharmacology , Dose-Response Relationship, Drug , Glycolysis/drug effects , Kinetics , Lactates/biosynthesis , Male , Mice , Ouabain/pharmacology , Oxygen Consumption , Respiration/drug effects
19.
Tumori ; 63(1): 15-24, 1977.
Article in English | MEDLINE | ID: mdl-301676

ABSTRACT

IgG and IgM participation in tumor rejection was studied in DBA/2 mice immunized against L1210 leukemia and in Swiss mice immunized against Ehrlich adenocarcinoma. In both the systems, IgM globulins seem to be implicated and are present on the cell surface of macrophages, lymphocytes and cancer cells, while IgG globulins are present only on some lymphocytes. IgM are also present in the peritoneal washing fluids (obtained 24 h of the control group. In the former group, protein content is about three times higher than that in the control group, while the relative amount of heavy proteins (18 S) and light proteins (7 S) is quite similar. These observations are discussed, as is the possibility that some complement components as C3 may participate in the reaction.


Subject(s)
Carcinoma, Ehrlich Tumor/immunology , Immunoglobulin M , Leukemia L1210/immunology , Animals , Antigen-Antibody Reactions , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Blood Proteins/metabolism , Carcinoma, Ehrlich Tumor/metabolism , Immunoglobulin G/metabolism , Immunoglobulin M/metabolism , Leukemia L1210/metabolism , Macrophages/immunology , Macrophages/metabolism , Mice , Mice, Inbred DBA , Mice, Inbred Strains , Rabbits , T-Lymphocytes/immunology , T-Lymphocytes/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...